Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Notice Shareholders of Boston Scientific (NYSE: BSX): Corcept Therapeutics (NASDAQ: CORT); Nektar Therapeutics (NASDAQ: NKTR); and Unicycive (NASDAQ: UNCY)
-
ATTN Shareholders of Corcept (NASDAQ: CORT); Kyndryl (NYSE: KD); Molina Healthcare, Inc. (NYSE: MOH); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY)
-
PHILADELPHIA, March 03, 2026 (GLOBE NEWSWIRE) -- Corcept Therapeutics, Inc. (NASDAQ: CORT): WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Corcept...
-
PHILADELPHIA, March 02, 2026 (GLOBE NEWSWIRE) -- Corcept Therapeutics, Inc. (NASDAQ: CORT): WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Corcept...
-
The lawsuit alleges that defendants failed to disclose that the FDA raised concerns about the adequacy of evidence supporting relacorilant’s NDA.
-
The lawsuit alleges that defendants failed to disclose that the FDA raised concerns about the adequacy of evidence supporting relacorilant’s NDA.
-
Corcept Therapeutics (CORT) under investigation following report of previous FDA warnings. Block & Leviton encourages investors to contact the firm.
-
Block & Leviton is investigating Corcept Therapeutics for possible securities fraud. Investors with losses should contact the firm.
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Dec. 29, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Corcept Therapeutics Inc....
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Dec. 09, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Corcept Therapeutics Inc....